Design 20 February 2026

Figma stock price dips before the bell as FIG traders eye March AI credits shift

Figma shares fell 1.95% to $25.58 in premarket trading Monday after a volatile week and ahead of a Feb. 25 product update. The company reported a Q4 net loss of $226.6 million despite 41% annual revenue growth. Investors are watching the March rollout of paid AI credits. U.S. index futures also declined on renewed tariff uncertainty.

February 23, 2026

Design·Finance·News·Technology

Figma stock price today: FIG dips in premarket after AI-fueled pop, March pricing shift in focus

Figma shares slipped 1.2% to $25.54 in premarket trading Friday after a 6.9% surge Thursday. The company forecast 2026 revenue above expectations, but analysts flagged margin risks as Figma shifts AI features to metered credits in March. Fourth-quarter revenue rose 40% to $303.8 million. Stifel cut its price target to $30, citing uncertainty over AI-related costs.

February 20, 2026

Why UK Healthcare Stocks Are Gaining Investor Interest
May 26, 2026, 2:12 PM EDT. UK healthcare stocks are drawing attention due to sector-specific developments and broader market trends. Investors are assessing regulatory changes, innovation in medical technologies, and post-pandemic healthcare demand shifts. Regulatory oversight by the Financial Conduct Authority (FCA) ensures market integrity and investor protection. Despite increased interest, investors are advised to consult qualified financial advisers to tailor strategies to individual risk tolerance. Kalkine Media provides insights without endorsing specific investments. The sector's appeal lies in its potential for growth amid evolving healthcare needs and government policies, underscoring the importance of informed investment decisions in the UK healthcare market.